ICUI | ICU Medical, Inc.

Index- P/E- EPS (ttm)-1.92 Insider Own1.50% Shs Outstand24.01M Perf Week2.35%
Market Cap4.41B Forward P/E21.93 EPS next Y8.61 Insider Trans-0.75% Shs Float20.08M Perf Month-9.22%
Income-46.00M PEG- EPS next Q1.62 Inst Own96.60% Short Float / Ratio5.75% / 6.45 Perf Quarter23.28%
Sales2.31B P/S1.91 EPS this Y-165.70% Inst Trans-3.43% Short Interest1.15M Perf Half Y23.77%
Book/sh87.47 P/B2.16 EPS next Y22.18% ROA-1.00% Target Price213.00 Perf Year7.55%
Cash/sh9.59 P/C19.69 EPS next 5Y16.00% ROE-2.20% 52W Range128.90 - 212.43 Perf YTD19.89%
Dividend- P/FCF- EPS past 5Y-23.80% ROI-0.10% 52W High-11.12% Beta0.63
Dividend %- Quick Ratio1.00 Sales past 5Y12.00% Gross Margin31.30% 52W Low46.47% ATR5.52
Employees14500 Current Ratio2.60 Sales Q/Q4.70% Oper. Margin0.40% RSI (14)53.91 Volatility2.50% 2.82%
OptionableYes Debt/Eq0.79 EPS Q/Q74.60% Profit Margin-2.00% Rel Volume0.61 Prev Close191.93
ShortableYes LT Debt/Eq0.77 EarningsMay 08 AMC Payout- Avg Volume179.15K Price188.80
Recom2.30 SMA200.87% SMA503.53% SMA20013.18% Volume108,846 Change-1.63%
Date Action Analyst Rating Change Price Target Change
Nov-08-22Downgrade Raymond James Outperform → Mkt Perform
Mar-31-20Upgrade CJS Securities Market Perform → Market Outperform
Mar-18-20Upgrade KeyBanc Capital Markets Sector Weight → Overweight $206
Aug-08-19Downgrade Raymond James Strong Buy → Outperform
Oct-17-17Initiated KeyBanc Capital Mkts Sector Weight
Jun-20-17Downgrade Sidoti Buy → Neutral
Mar-11-16Initiated Gabelli & Co Buy $128
Nov-06-15Reiterated ROTH Capital Buy $124 → $130
Aug-11-15Reiterated ROTH Capital Buy $102 → $124
May-06-15Reiterated ROTH Capital Buy $96 → $102
May-10-23 06:09AM
May-09-23 05:25PM
May-08-23 05:35PM
04:05PM Loading…
Apr-26-23 08:00PM
Apr-24-23 07:56PM
Apr-11-23 07:07AM
Mar-29-23 09:47AM
Mar-15-23 05:55PM
Mar-09-23 08:30AM
Mar-02-23 05:44AM
Mar-01-23 07:11PM
05:15AM Loading…
Feb-28-23 11:05AM
Feb-27-23 06:15PM
Feb-26-23 08:04AM
Feb-21-23 08:30AM
Feb-13-23 08:30AM
Feb-08-23 08:00AM
Jan-23-23 08:55AM
Jan-20-23 07:21PM
Dec-19-22 08:30AM
Dec-03-22 07:28AM
Nov-07-22 06:35PM
07:21AM Loading…
Nov-06-22 07:21AM
Nov-01-22 09:00AM
Oct-31-22 04:01PM
Oct-07-22 10:08AM
Oct-06-22 08:30AM
Sep-26-22 08:18AM
Sep-08-22 08:30AM
Aug-09-22 03:15PM
Aug-08-22 06:15PM
Jul-19-22 08:30AM
Jun-18-22 08:51AM
May-19-22 08:05AM
May-11-22 04:12PM
May-09-22 05:45PM
May-06-22 03:18AM
May-05-22 02:52AM
May-04-22 03:05AM
Apr-20-22 08:30AM
Apr-19-22 07:51AM
Apr-14-22 02:37AM
Apr-13-22 06:54AM
Apr-12-22 02:31AM
Apr-11-22 05:04AM
Apr-08-22 02:37AM
Mar-24-22 08:03AM
Mar-23-22 12:00PM
Mar-22-22 12:45PM
Mar-14-22 08:30AM
Mar-10-22 12:48PM
Mar-05-22 08:42AM
Mar-04-22 09:40AM
Mar-03-22 12:45PM
Mar-02-22 08:30AM
Feb-24-22 06:20PM
Feb-17-22 03:02PM
Feb-07-22 02:29PM
Feb-04-22 08:30AM
Jan-28-22 12:45PM
Jan-19-22 09:38AM
Jan-18-22 05:38PM
Jan-06-22 04:30PM
Dec-29-21 08:30AM
Dec-13-21 07:43AM
Dec-10-21 09:18AM
Dec-09-21 07:38PM
Dec-08-21 07:21AM
Nov-03-21 09:31PM
Oct-27-21 03:03PM
Oct-24-21 10:48AM
Oct-18-21 01:35PM
Oct-13-21 08:30AM
Sep-18-21 10:31AM
Sep-15-21 10:40AM
Sep-09-21 09:34AM
Sep-08-21 04:17PM
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; and ClearGuard HD, that maintains hemodialysis catheters. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 brand; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform that connects smart pumps to hospital's electronic health records, asset tracking systems, and alarm notification platforms; professional services; critical care products, such as Cogent 2-in-1 and CardioFlo hemodynamic monitoring systems; TDQ and OptiQ cardiac output monitoring catheters; TriOx venous oximetry catheters; Transpac blood pressure transducers; and SafeSet closed blood sampling and conservation systems. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FINNEY ELISHA WDirectorJun 07Sale190.4119436,9401,481Jun 07 04:26 PM
KENNEDY KOLLEEN TDirectorMay 17Option Exercise0.004850614May 18 12:51 PM
Hoffmeister David FDirectorMay 17Option Exercise0.0048502,079May 18 12:46 PM
FINNEY ELISHA WDirectorMay 17Option Exercise0.0048501,675May 18 12:41 PM
Abbey DonaldDirectorMay 17Option Exercise0.0048502,079May 18 12:37 PM
Hernandez LaurieDirectorMay 17Option Exercise0.004850937May 18 12:19 PM
Greenberg David C.DirectorMay 17Option Exercise0.0048504,089May 18 12:15 PM
Sanzone Virginia RuthVP, General CounselApr 11Sale175.0025043,7504,678Apr 11 02:11 PM
Sanzone Virginia RuthVP, General CounselApr 05Sale170.0045877,8604,928Apr 05 05:07 PM
Woolson DanielVP, GM-Infusion CapitalMar 08Option Exercise0.002,020012,500Mar 08 05:09 PM
Sanzone Virginia RuthVP, General CounselMar 08Option Exercise0.002,27206,582Mar 08 05:06 PM
Voigtlander Christian B.Chief Operating OfficerMar 08Option Exercise0.002,209021,616Mar 08 04:59 PM
Jain VivekChairman and CEOMar 08Option Exercise0.002,525025,091Mar 08 04:56 PM
Bonnell Brian MichaelChief Financial OfficerMar 08Option Exercise0.002,209013,578Mar 08 04:52 PM
Woolson DanielVP, GM-Infusion CapitalMar 07Option Exercise0.00965010,908Mar 08 05:09 PM
Sanzone Virginia RuthVP, General CounselMar 07Option Exercise0.001,07204,874Mar 08 05:06 PM
Voigtlander Christian B.Chief Operating OfficerMar 07Option Exercise0.002,145020,536Mar 08 04:59 PM
Jain VivekChairman and CEOMar 07Option Exercise0.003,218024,260Mar 08 04:56 PM
Bonnell Brian MichaelChief Financial OfficerMar 07Option Exercise0.002,145012,498Mar 08 04:52 PM
Woolson DanielVP, GM-Infusion CapitalMar 06Option Exercise0.001,417010,569Mar 08 05:09 PM
Sanzone Virginia RuthVP, General CounselMar 06Option Exercise0.001,59504,641Mar 08 05:06 PM
Voigtlander Christian B.Chief Operating OfficerMar 06Option Exercise0.0010,296022,260Mar 08 04:59 PM
Jain VivekChairman and CEOMar 06Option Exercise0.0011,767026,303Mar 08 04:56 PM
Bonnell Brian MichaelChief Financial OfficerMar 06Option Exercise0.0010,296014,957Mar 08 04:52 PM
Woolson DanielVP, GM-Infusion CapitalFeb 02Sale200.001,731346,2009,152Feb 02 02:57 PM
Sanzone Virginia RuthVP, General CounselNov 15Sale160.1232552,0393,046Nov 15 05:24 PM
LOPEZ GEORGE ADirectorSep 21Option Exercise61.7679,5764,914,614361,020Sep 21 05:36 PM